CYP11B2 polymorphisms and home blood pressure in a population-based cohort in Japanese: The Ohasama study

Hypertension Research

Volumn 27, Issue 1, 2004, Pages 1-6

  Matsubara, Mitsunobu ^a   Sato, Tomomi ^b   Nishimura, Takuya ^b   Suzuki, Michiko ^a   Kikuya, Masahiro ^b   Metoki, Hirohito ^a   Michimata, Mari ^a,b   Tsuji, Ichiro ^c   Ogihara, Toshio ^d   Imai, Yutaka ^b  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Aldosterone; Aldosterone synthase; Cortisol; Hypertension

Indexed keywords

ALDOSTERONE SYNTHASE; CYTOSINE; THYMINE;

ADULT; AGE; ALLELE; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; EXON; FEMALE; GENE CONVERSION; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENE TARGETING; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEREDITY; HUMAN; HYPERTENSION; INTRON; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POPULATION RESEARCH; PREVALENCE; PROMOTER REGION; RURAL AREA; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

AGED; ALDOSTERONE SYNTHASE; ARTERIOSCLEROSIS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; COHORT STUDIES; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; INTRONS; JAPAN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 10744220308     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.27.1     Document Type: Article

References (24)

1. Brand E, Chatellain N, Mulatero, P, et al: Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension 1998; 32: 198-204.
2. Matsubara M: Genetic determination of human essential hypertension. Tohoku J Exp Med 2000; 192: 19-33.
3. Brand E, Chatelain N, Mulatero P, et al: Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension 1998; 32: 198-204.
4. Pojoga L, Gautier S, Blanc H, et al: Genetic determination of plasma aldosterone, levels in essential hypertension. Am J Hypertens 1998; 11: 856-860.
5. Davies E, Holloway CD, Ingram MC, et al: Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. Hypertension 1999; 33: 703-707.
6. Brand E, Schorr U, Ringel J, Beige J, Distler A, Sharma AM: Aldosterone synthase gene (CYP11B2) C-344T polymorphisms in Caucasians from Berlin salt-sensitivity trial (BeSST). J Hypertens 1999; 17: 1563-1567.
7. Mulatero P, Schiavone D, Fallo F, et al: CYP11B2 gene polymorphisms in idiopathic hyperaldosteronism. Hypertension 2000; 35: 694-698.
8. Rossi E, Regolisti G, Perazzoli F, et al: -344C/T polymorphism of CYP11B2 gene in Italian patients with idiopathic low renin hypertension. Am J Hypertens 2001; 14: 934-941.
9. Delles C, Erdmann J, Jacobi J, et al RE: Aldosterone synthase (CYP11B2) -344C/T polymorphism is associated with left ventricular structure in human arterial hypertension. J Am Coll Cardiol 2001; 37: 878-884.
10. Matsubara M, Kikuya M, Ohkubo T, et al: Aldosterone synthase gene (CYP11B2) C-344T polymorphism, ambulatory blood pressure and nocturnal decline in blood pressure in the general Japanese population: the Ohasama study. J Hypertens 2001; 19: 2179-2184.
11. Tsujita Y, Iwai N, Katsuya T, et al: Lack of association between genetic polymorphism of CYP11B2 and hypertension in Japanese: the Suita Study. Hypertens Res 2001; 24: 105-109.
12. White PC and Slutsker L: Haplotype analysis of CYP11B2. Endocr Res 1995; 21: 437-442.
13. Matsubara M, Omori F, Fujita S, et al: Haplotypes of CYP11B2 gene in the general population of Japan: the Ohasama study. Clin Exp Hypertens 2001; 23: 603-610.
14. Matsubara M, Suzuki M, Fujiwara, T, et al: Angiotensin converting enzyme I/D polymorphism and hypertension: the Ohasama study. J Hypertens 2002; 20: 1121-1126.
15. Fujiwara T, Katsuya T, Matsubara M, et al: T+31C polymorphism of angiotensinogen gene and nocturnal blood pressure decline: the Ohasama Study. Am J Hypertens 2002; 15: 628-632.
16. 1166 gene polymorphism of the angiotensin II type 1 receptor (AT1) and ambulatory blood pressure; the Ohasama Study. Hypertens Res 2003; 26: 141-145.
17. Matsubara M, Metoki H, Katsuya T, et al: T+31C polymorphisms (M235T) of the angiotensinogen gene and home blood pressure in the Japanese general population: the Ohasama study. Hypertens Res 2003; 26: 27-52.
18. Matsubara M, Ohkubo T, Michimata M, et al: Japanese individuals do not harbor the T594M mutation but do have the P592S mutation in the C-terminus of the beta-subunit of the epithelia] sodium channel: the Ohasama study. J Hypertens 2000; 18: 861-866.
19. Matsubara M, Metoki H, Suzuki M, et al: Genotypes of the beta ENaC gene have little influence on blood pressure level in the Japanese population. Am J Hypertens 2002; 15: 189-192.
20. Guidelines Subcommittee: 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. J Hypertens 1999; 17: 151-184.
21. Uzu T, Kazembe FS, Ishikawa K, Nakamura S, Inenaga T, Kimura G: High sodium sensitivity implicates nocturnal hypertension in essential hypertension. Hypertension 1996; 28: 139-142.
22. Uzu T, Ishikawa K, Fujii T, et al: Sodium restriction shifts circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation 1997; 16: 1859-1862.
23. Higashi Y, Oshima T, Ozono R, et al: Nocturnal decline in blood pressure is attenuated by NaCl loading in salt-sensitive patients with essential hypertension: noninvasive 24-hour ambulatory blood pressure monitoring. Hypertension 1997; 30: 163-167.
24. Uzu T, Nishimura M, Fujii T, et al: Change in the circadian rhythm of blood pressure in primary aldosteronism in response to dietary sodium restriction and adrenalectomy. J Hypertens 1998; 16: 1745-1748.